Satisfying your needs

Hovione is an independent laboratory with expertise in every aspect of inhaled formulation development, from manufacturing the API to delivering it via inhalation and including particle-size reduction, formulation development and testing, blending preparation, capsule filling, in vitro testing and in vivo trials. For either feasibility studies or industrial scale-up processes, whatever the issue, Hovione has the capability to solve it.

Our goal
Hovione aims at delivering premium inhalation drug products and devices using state-of-the-art technology, continually improving processes and operations to meet customer demands.

GMP and compliance
Hovione operates in a highly compliant environment strengthened by 25 years of FDA inspections and hundreds of customer audits. Our development effort is focused on obtaining NDA as well as ANDAS approvals.
Hovione is licensed by Infarmed, the Portuguese health authority, to manufacture and supply inhalers and capsule-based dry powder formulations for phase I and II clinical trials.

Your investment is protected
Access to technology and know-how is guaranteed. If your project requires the use of Hovione’s powder technology you will obtain a royalty-free license to use it. If we develop the technology under contract, you will own it and be free to patent it, provided Hovione may continue using the technology for non-competing uses.
Concerning the inhaler devices, the choice is yours. We can develop your inhalation product using our royalty-bearing inhalers FlowCaps® or TwinCapsTM , or, alternatively, any another device of your choice.

Scientific collaboration
With inhalation formulation a new and exciting scientific domain, once you entrust us with your project, Hovione will foster a close and continuous scientific collaboration to discuss, plan ahead and anticipate pharmaceutical, clinical and regulatory issues.